Gastrointestinal tract microbiota modulation via prebiotic effect

Gastrointestinal tract microbiota modulation via prebiotic effect" refers to the process by which **prebiotic compounds**—non-digestible food ingredients—selectively stimulate the growth and/or activity of beneficial microorganisms within the human gut. This is not a single molecular target but rather a therapeutic strategy aimed at shifting the composition and metabolic output of complex microbial communities residing in the intestine. Prebiotics such as fructooligosaccharides, galactooligosaccharides, lactulose, pectin, cellulose, and xylan have been shown to increase populations like bifidobacteria and lactic acid bacteria while promoting production of health-promoting metabolites including short-chain fatty acids. These changes can positively influence host metabolism, immunity, gastrointestinal function—and even brain health through mechanisms involving immune signaling and metabolite-mediated communication along the gut-brain axis.[1][2][3][4] This entry does **not** represent a discrete molecular entity or classical drug target such as an enzyme or receptor; rather it describes an intervention strategy affecting a complex ecosystem.

Other names

Gut microbiota modulation by prebioticsPrebiotic-induced gut microbiota changesPrebiotic effect on intestinal microbiome

Prebiotics act by being selectively utilized by beneficial host microorganisms in the gastrointestinal tract. This leads to increased growth and activity of these microbes and production of metabolites like SCFAs that confer health benefits. Mechanisms include competition for nutrients/sites, inhibition of pathogens through metabolite production, and immune modulation.[1][2][4]